Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
A world on weight loss drugs: How GLP-1s are reshaping the economy
August 26, 2025
Tags
Hotels and Leisure
Food and drink
Diageo PLC
From
CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
August 24, 2025
Tags
Structure Therapeutics Inc
Biotechnology
Companies
From
CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
August 19, 2025
Tags
Pfizer Inc
US: News
Eli Lilly and Co
From
CNBC.com News
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
August 12, 2025
Tags
Business
Moderna Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
August 05, 2025
Tags
AstraZeneca PLC
Health care industry
Eli Lilly and Co
From
CNBC.com News
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
August 05, 2025
Tags
Business
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
August 01, 2025
Tags
Dupont De Nemours Inc
Dutch Bros Inc
Stock Picks
From
CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
August 01, 2025
Tags
Sanofi SA
Merck & Co Inc
Johnson & Johnson
From
CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Health & Science
Elanco Animal Health Inc
GSK plc
From
CNBC.com News
Cramer's Lightning Round: Lowe's is a buy
July 23, 2025
Tags
stocks
CrowdStrike Holdings Inc
Business
From
CNBC.com News
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
July 17, 2025
Tags
Breaking News: Business
Health & Science
Pharmaceuticals
From
CNBC.com News
Inside the trade war's tariff hideouts, 'foreign' zones and bonded warehouses
July 12, 2025
Tags
Sony Group Corp
State of Freight
Pfizer Inc
From
CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
Tags
Gilead Sciences Inc
Pfizer Inc
Healthy Returns
From
CNBC.com News
Tripadvisor stock surges 10% as Starboard Value builds sizable stake in online travel company
July 03, 2025
Tickers
LIFE
Tags
Enterprise
Travel
stocks
From
CNBC.com News
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
June 30, 2025
Tags
Breaking News: Business
Business News
Novavax Inc
From
CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
June 17, 2025
Tags
Amgen Inc
Social issues
Breaking News: Politics
From
CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
June 17, 2025
Tags
Merck & Co Inc
Johnson & Johnson
Breaking News: Business
From
CNBC.com News
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say
June 10, 2025
Tags
Health & Science
Pharmaceuticals
Biontech SE
From
CNBC.com News
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
June 09, 2025
Tags
Business
Moderna Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
June 03, 2025
Tags
Gilead Sciences Inc
Pfizer Inc
Healthy Returns
From
CNBC.com News
Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
May 28, 2025
Tags
Hinge Health Inc
Healthy Returns
Pfizer Inc
From
CNBC.com News
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
May 20, 2025
Tags
Biotech and Pharmaceuticals
Moderna Inc
Novavax Inc
From
CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
May 12, 2025
Tags
U/S/ Markets
Markets
Business
From
CNBC.com News
Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know
May 12, 2025
Tags
Pharmaceuticals
Business News
Social issues
From
CNBC.com News
Trump to sign order to cut some U.S. drug prices to match those abroad
May 12, 2025
Tags
Health & Science
LILLY DRN
Social issues
From
CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 02, 2025
Tags
LILLY DRN
Amgen Inc
Abbvie Inc
From
CNBC.com News
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
April 29, 2025
Tags
Health care industry
Companies
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Tuesday
April 29, 2025
Tags
Investment strategy
United Parcel Service Inc
Technology
From
CNBC.com News
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
April 29, 2025
Tags
Biotech and Pharmaceuticals
Business
Biotechnology
From
CNBC.com News
Corporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses
April 23, 2025
Tags
General Electric Co
Toyota Motor Corp
Alphabet Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.